Healthcare
Charlotte's Web Holdings, Inc.(CWBHF)
Live Price
Offline$0.301
-14.73% today
1Y Change
+292.55%
Window
Jun 25, 2025 β Jun 16, 2026
- Market Cap
- $80.00M
- Revenue Growth
- +0.5%
- EPS Growth
- 0.0%
- Dividend Yield
- 0.0%
Coverage: 245 bars Β· Jun 25, 2025 β Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Charlotte's Web Holdings, Inc. (CWBHF) is a Healthcare stock with a market cap of $80.00M and listed on OTC. The stock last traded around $0.30 and up 292.6% across the available one-year price window (Jun 25, 2025 β Jun 16, 2026). Baseline metrics include revenue growth of +0.5%, EPS growth of 0.0%, a dividend yield of 0.0%. What stands out right now is revenue +0.5%, EPS 0.0%, free cash flow +41.6% with operating margin -40.6% and ROIC -29.1%. Valuation is more restrained than many high-expectation growth names at price/sales 1.5. Stock Foundry combines CWBHF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+0.5% vs +7.6% peer median
Operating Margin
Below sector median
-40.6% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 13, 2026, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is +0.5% and EPS is 0.0%, while operating margin sits near -40.6%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -6.1% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS Ξ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | β | -7.0% | -9.5% | -17.7% |
2026 Mar 31, 2026 | -140.0% | +6.4% | -18.4% | -26.5% |
2025 Nov 12, 2025 | -22.3% | +5.9% | +9.4% | +15.3% |
Benchmark Edge
CWBHF vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CWBHF
β
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CWBHF Max Drawdown
-59.89%
Trailing 1Y
SPY Max Drawdown
β
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for CWBHF and SPY.
Company Overview
Charlotte's Web Holdings, Inc.
OTC
Charlotte's Web Holdings, Inc. is a leading producer and distributor of hemp-derived wellness products. The company's primary focus is on producing high-quality cannabidiol (CBD) extracts, which are used in a variety of consumer health and wellness products. Charlotte's Web's offerings include tinctures, capsules, topicals, and pet products, all formulated with natural ingredients to support health balance and overall wellbeing. With its founding roots linked to providing therapeutic benefits, particularly highlighted by its efficacious impact on a young child named Charlotte Figi, Charlotte's Web has become synonymous with high-standard CBD production. The company grows its hemp in the United States, ensuring that its products meet stringent quality standards from cultivation to final product. In the financial markets, Charlotte's Web plays a crucial role in the burgeoning cannabis sector, catering to the increasing consumer demand for natural wellness alternatives. The companyβs innovative approach and commitment to sustainable practices have positioned it as a trailblazer within the CBD industry, paving the way for expanded market growth and consumer education on the benefits of hemp-based products.
- Leadership
- Mr. William J. Morachnick
- Employees
- 112
- Street Address
- 700 Tech Court
- Mailing
- Louisville, CO, 80027
- Region
- Louisville, CO, United States
- Last Updated
- May 9, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- β
- EV/EBITDA
- β
- Price/Sales
- 1.5
- Price/Book
- β
Growth
- Revenue
- +0.5%
- EPS
- 0.0%
- Free Cash Flow
- +41.6%
Profitability
- Gross Margin
- 43.5%
- Operating Margin
- -40.6%
- Net Margin
- -59.6%
- ROE
- -275.4%
- ROIC
- -29.1%
Balance Sheet
- Debt/Equity
- β
- Current Ratio
- 3.51
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.